search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
table 1. Mycobactericidal Effects of Aldehyde-Based Products Against GTA-Susceptible and GTA-Resistant Mycobacterium Isolates in Suspension Testsa


Product Tested


Mmas CIP108297 (GTAS)


Cidex (1.5% GTA), 25°C 0 min 5 min


8.20


10 min 15 min 30 min 0 min


45 min


5.27±0.08 0 0 0


nd nd


Aldahol (1.8% GTA), 20°C 0 min 5 min


10 min 15 min 30 min


7.25 0 0 0 0


Aldahol (1.8% GTA), 25°C 0 min 5 min


10 min 15 min 30 min


7.25 0 0 0 0


15% Isopropanol, 25°C 0 min 5 min


8.31 8.36±0.07


10 min 8.53±0.15 15 min 8.43±0.03 30 min 8.32±0.05


Cidex OPA (0.3% OPA), 25°C 0 min 5 min


10 min 15 min 30 min


12 min 30 min


7.25 0 0 0 0


Cidex OPA (0.3% OPA), 20°C 0 min


nd nd nd


Mmas CRM-0270 (GTAS)


8.29 0 0 0 0


nd nd


8.29 0 0 0 0


8.29 0 0 0 0


nd nd nd nd nd


8.29 0 0 0 0


5.13 0 0


Mmas CRM-0019 (GTAR)


7.79


7.47±0.04 7.48±0.13 7.48±0.05 7.23±0.03 7.39


6.76±0.02 6.69


4.54±0.13 3.36±0.01 2.49±0.71 0


6.69 0 0 0 0


8.23


9.02±0.03 8.86±0.08 8.87±0.00 8.88±0.10


7.32 0 0 0 0


7.64 0 0


Mch ATCC 35752 (GTAS)


7.11 0 0 0 0


nd nd


7.11 0 0 0 0


7.11 0 0 0 0


nd nd nd nd nd


7.11 0 0 0 0


7.69 0 0


Mch 9917 (GTAR)


7.06 7.49


Mch Harefield (GTAR)


7.60


Mch Epping (GTAR)


7.65


7.55±0.05 7.96±0.00 8.02±0.11 7.87±0.06 7.95±0.02


6.95±0.21 7.70±0.05 7.91±0.04 7.23±0.03 7.50±0.09 7.73±0.04 8.83


8.33 7.60 8.38


5.63±0.38 6.85±0.15 7.20±0.01 7.06


7.65


7.39±0.09 7.78±0.00 7.45±0.04 7.64±0.01 7.15±0.17 7.44±0.08 6.97±0.04 7.17±0.03 6.65±0.00


7.27 6.97 6.13


8.13 0 0 0 0


nd nd nd nd nd


8.13 0 0 0 0


8.27 0 0


7.60


7.30±0.02 4.70±00 0 6.92±0.25 6.58±0.17 5.98±0.17


7.65 0


0 0


nd nd nd nd nd


7.63


3.92±0.21 0 0 0


7.65 0 0


nd nd nd nd nd


7.65 0 0 0 0


7.80 0 0


6.29 0


0 0


nd nd nd nd nd


6.29 0 0 0 0


nd nd nd


NOTE. GTA, glutaraldehyde; OPA, ortho-phthalaldehyde; CFU, colony-forming units; GTAR, GTA-resistant; GTAS, GTA-susceptible. nd,


not determined. aThe mean log10 CFU counts and standard deviations of duplicate tests for each strain and test product are shown. The 0-minute time point (enumeration of CFU in the bacterial suspension prior to disinfectant exposure) is the result of a single serial dilution plating. Control suspension tests using the GTA-susceptible isolate, M. massiliense CIP 108297, confirmed the neutralizing efficacy of the neutralizing broth with each disinfectant product. The detection limit of the suspension tests is 1 CFU/mL.


M. bovis BCG (Pasteur) (GTAS)


6.29


4.33±0.26 3.30±2.55 0 0


nd nd


6.29 0 0 0 0


M. avium 104 (GTAS)


8.04 nd


5.97±0.03 5.10±0.35 0


nd nd


8.16 0 0 0 0


8.32 0


0 0


nd nd nd nd nd


8.32 0 0 0 0


nd nd nd


M. terrae ATCC 15755 (GTAS)


7.97


4.70±0.18 3.81±0.14 3.18±0.21 0


nd nd


7.97 0 0 0 0


7.97 0 0 0 0


nd nd nd nd nd


7.97 0 0 0 0


nd nd nd


disinfectant susceptibility of mycobacteria 787


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136